Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review

Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon

(2009) Duk-Hee Lee et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Alanine Aminotransferase,  -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis

(2009) A. Fraser et al.   DIABETES CARE

Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants?

(2009) Duk-Hee Lee et al.   FREE RADICAL RESEARCH

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels

(2009) Robin Haring et al.   HEPATOLOGY

Nonalcoholic Fatty Liver Disease as a Contributor to Hypercoagulation and Thrombophilia in the Metabolic Syndrome

(2009) Giovanni Targher et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Longitudinal Change in Serum Gamma-Glutamyltransferase and Cardiovascular Disease Mortality

(2008) Alexander M. Strasak et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes

(2008) S.G. Wannamethee et al.   ATHEROSCLEROSIS

Association of  -Glutamyltransferase and Risk of Cancer Incidence in Men: A Prospective Study

(2008) A. M. Strasak et al.   CANCER RESEARCH

Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values

(2008) Maria Franzini et al.   CLINICA CHIMICA ACTA

Liver Enzymes and Incident Diabetes: Findings from the European Prospective Investigation Into Cancer and Nutrition (EPIC)-Potsdam Study

(2008) E. S. Ford et al.   DIABETES CARE

Liver Enzymes Compared With Alcohol Consumption in Predicting the Risk of Type 2 Diabetes: The Kansai Healthcare Study

(2008) K. K. Sato et al.   DIABETES CARE

Association of serum γ-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver

(2008) Chul-Hee Kim et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

(2008) G. Targher et al.   DIABETOLOGIA

Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population

(2008) Constance E. Ruhl et al.   GASTROENTEROLOGY

Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women

(2008) Alexander M. Strasak et al.   INTERNATIONAL JOURNAL OF CANCER

Non-alcoholic fatty liver disease: The mist gradually clears

(2008) Nimantha Mark Wilfred de Alwis et al.   JOURNAL OF HEPATOLOGY

Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease

(2008) G. Targher et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study

(2008) Matteo Monami et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men

(2008) Yoosoo Chang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fatty Liver

(2007) Anna Kotronen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY